Tags

Type your tag names separated by a space and hit enter

Central anticholinergic syndrome due to Jimson weed physostigmine: therapy revisited?
J Toxicol Clin Toxicol. 1998; 36(1-2):43-5.JT

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Case Reports
Letter

Language

eng

PubMed ID

9541041

Citation

Sopchak, C A., et al. "Central Anticholinergic Syndrome Due to Jimson Weed Physostigmine: Therapy Revisited?" Journal of Toxicology. Clinical Toxicology, vol. 36, no. 1-2, 1998, pp. 43-5.
Sopchak CA, Stork CM, Cantor RM, et al. Central anticholinergic syndrome due to Jimson weed physostigmine: therapy revisited? J Toxicol Clin Toxicol. 1998;36(1-2):43-5.
Sopchak, C. A., Stork, C. M., Cantor, R. M., & Ohara, P. E. (1998). Central anticholinergic syndrome due to Jimson weed physostigmine: therapy revisited? Journal of Toxicology. Clinical Toxicology, 36(1-2), 43-5.
Sopchak CA, et al. Central Anticholinergic Syndrome Due to Jimson Weed Physostigmine: Therapy Revisited. J Toxicol Clin Toxicol. 1998;36(1-2):43-5. PubMed PMID: 9541041.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Central anticholinergic syndrome due to Jimson weed physostigmine: therapy revisited? AU - Sopchak,C A, AU - Stork,C M, AU - Cantor,R M, AU - Ohara,P E, PY - 1998/4/16/pubmed PY - 1998/4/16/medline PY - 1998/4/16/entrez SP - 43 EP - 5 JF - Journal of toxicology. Clinical toxicology JO - J Toxicol Clin Toxicol VL - 36 IS - 1-2 SN - 0731-3810 UR - https://wwww.unboundmedicine.com/medline/citation/9541041/Central_anticholinergic_syndrome_due_to_Jimson_weed_physostigmine:_therapy_revisited DB - PRIME DP - Unbound Medicine ER -